2025 Newsletters from The Collective

August 2025: How Pricing Transparency Plays into Strategic Decision Making; New Blood Pressure Recommendations; “No Surprises” Act
July 2025: Drug Manufacturer Rebates; Drug Pricing Explained; 2025 Trends in Drug Benefit Design; Prior Authorizations Update
June 2025: Why is it So Hard to Cut Healthcare Costs?; How Employers Can Fight the Price Crisis; Virtual Solutions for Depression & Anxiety
May 2025: Rethinking How Employers Address High-Cost Claims; Trends in Specialty Drug Benefits; What’s Happening in Pain Treatment Alternatives?
April 2025: 2026 Plan Prep; What President Trump’s Executive Order on Drug Pricing Means for Employers; Cardiovascular Disease, Diabetes and Obesity in Women
March 2025: Copay Accumulator and Maximizer Programs; Oklahoma Health Insurance Mandates Increase Costs; Measles Boosters
February 2025: Mental Health Coverage Law Compliance; Understanding Your Fiduciary Responsibilities; Colorectal Cancer Awareness Month
January 2025: Advancing Primary Care–A Purchasing Playbook for Action; Key Drug Patents Expiring in 2025; Removing medical debt from credit reports